Basile, M., Rumi, F., & Cicchetti, A. (2021). Budget Impact analysis of ponatinib for the management of patients with chronic myeloid leukemia. Global and Regional Health Technology Assessment, 8(1), 87–95. https://doi.org/10.33393/grhta.2021.2238